For this reason, we hypothesized that carboplatin might mainly influence the hematopoiesis in earlier stage since prominent JAK2 downregulation-associated thrombocytopenia is found in our study both in vivo and in vitro. The gene discussed is JAK2; the disease is Thrombocytopenia.